科倫藥業(002422.SZ)擬以5000萬-10000萬元回購公司股份
格隆匯 1 月 20日丨科倫藥業(002422.SZ)公佈,公司擬使用自有資金以集中競價交易方式回購公司股份,在綜合考慮公司目前的財務結構和研發持續投入等因素下,確定本次回購資金總額為不低於人民幣5000萬元,不超過10000萬元;本次回購股份的價格為不超過人民幣24元/股(含),未超過公司董事會通過回購股份決議前三十個交易日公司股票交易均價的150%。具體回購數量以回購期滿時實際回購的股份數量為準。回購股份期限為自董事會審議通過回購股份方案之日起12個月內。
基於對公司未來發展前景的信心和對公司價值的認可,為進一步健全公司長效激勵機制,充分調動公司核心骨幹及優秀員工的積極性,共同促進公司的長遠發展,公司在考慮業務發展前景、經營情況、財務狀況、未來盈利能力以及近期公司股票在二級市場表現的基礎上,擬以自有資金回購公司部分社會公眾股份,用於實施員工持股計劃或股權激勵。但若公司未能在此次回購完成之後36個月內將回購股份用於員工持股計劃或股權激勵,則公司回購的股份將在依法履行程序後予以註銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.